ERBB2 and breast cancer: Furthermore, De Cola et al. indicated that miR-205-5p was significantly upregulated in HER2+ patient-derived breast cancer stem cells (BCSCs) compared with the same cells grown in differentiating spheroid conditions, sphere-derived adherent cells (SDACs) [69].